Drug profile · INN
ranitidine hydrochloride
RANITIDINE HYDROCHLORIDE
ranitidine hydrochloride (RANITIDINE HYDROCHLORIDE) is a histamine h2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — ranitidine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
ranitidine hydrochloride (RANITIDINE HYDROCHLORIDE) is a histamine h2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H2 receptor antagonist
Primary target: Histamine H2 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ranitidine hydrochloride?
ranitidine hydrochloride (RANITIDINE HYDROCHLORIDE) is a histamine h2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ranitidine hydrochloride?
RANITIDINE HYDROCHLORIDE is a marketed brand name for ranitidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ranitidine hydrochloride?
ranitidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.